CNRIP1 and schizophrenia: CRIP1a has been linked to neuropathological states such as epilepsy and neurotoxicity in the hippocampus [11,12,13,14], schizophrenia phenotype [15,16], and motor dysfunction and addiction in the striatum [17], making the CRIP1a-CB1 receptor interaction an accessible target for novel drug design.